BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18641991)

  • 1. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect.
    Kato H; Kanematsu M; Tanaka O; Mizuta K; Aoki M; Shibata T; Yamashita T; Hirose Y; Hoshi H
    Eur Radiol; 2009 Jan; 19(1):103-9. PubMed ID: 18641991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
    King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
    Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.
    Matoba M; Tuji H; Shimode Y; Toyoda I; Kuginuki Y; Miwa K; Tonami H
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):379-85. PubMed ID: 24029391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.
    King AD; Keung CK; Yu KH; Mo FK; Bhatia KS; Yeung DK; Tse GM; Vlantis AC; Ahuja AT
    AJNR Am J Neuroradiol; 2013; 34(6):1237-41. PubMed ID: 23306012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging of head and neck squamous cell carcinomas.
    Friedrich KM; Matzek W; Gentzsch S; Sulzbacher I; Czerny C; Herneth AM
    Eur J Radiol; 2008 Dec; 68(3):493-8. PubMed ID: 19189427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.
    Dirix P; Vandecaveye V; De Keyzer F; Stroobants S; Hermans R; Nuyts S
    J Nucl Med; 2009 Jul; 50(7):1020-7. PubMed ID: 19525447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive prediction of the tumor growth rate using advanced diffusion models in head and neck squamous cell carcinoma patients.
    Fujima N; Sakashita T; Homma A; Harada T; Shimizu Y; Tha KK; Kudo K; Shirato H
    Oncotarget; 2017 May; 8(20):33631-33643. PubMed ID: 28430583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
    Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
    Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.
    Kim S; Loevner L; Quon H; Sherman E; Weinstein G; Kilger A; Poptani H
    Clin Cancer Res; 2009 Feb; 15(3):986-94. PubMed ID: 19188170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
    Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas.
    Nakamatsu S; Matsusue E; Miyoshi H; Kakite S; Kaminou T; Ogawa T
    Clin Imaging; 2012; 36(2):90-7. PubMed ID: 22370129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis.
    Hauser T; Essig M; Jensen A; Laun FB; Münter M; Maier-Hein KH; Stieltjes B
    Eur J Radiol; 2014 May; 83(5):783-7. PubMed ID: 24631600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma.
    Razek AA; Nada N
    NMR Biomed; 2016 Apr; 29(4):483-9. PubMed ID: 26867020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.